KCAS-blog-thumb_2024-08_TargetedProtein Blogs
Read article The Role of Flow Cytometry in Targeted Protein Degradation

The exploration of Targeted Protein Degraders (TPD) as a therapeutic modality began over twenty years ago. Since then, research and development in this field have steadily advanced. Starting in 2019, rationally designed small molecule TPDs entered clinical trials. This innovative therapeutic modality utilizes the cells’ endogenous protein degradation machinery to…